Perimenopausal use of reproductive hormones effects on breast and endometrial cancer.
The effect of reproductive hormone use in the form of oral contraception or HRT on endometrial cancer incidence is not caused by simply bias: the epidemiologic studies are consistent; the effect of ERT is large; the biologic rationale cited is a plausible mechanism; and the response to progestin in oral contraception or combined HRT tends to confirm the biologic mechanism. In contrast, it remains unclear whether changes in breast cancer incidence following use of oral contraception and HRT are caused by hormone exposure or to other factors: the results of epidemiologic studies are not entirely consistent, and the smaller relative effect on risk of breast cancer is susceptible to bias and other sources of error. Although the exact nature of the association between repro ductive hormone use and breast cancer incidence is not yet clear, breast cancer is a common neoplasm in older women. Prescribers and users should take this into account in weighing benefits to ensure that unnecessary risks are avoided.
D001943:Breast Neoplasms / Q000139:chemically induced* / Q000453:epidemiology / Q000235:genetics; D002979:Climacteric; D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects*; D016889:Endometrial Neoplasms / Q000139:chemically induced* / Q000453:epidemiology / Q000235:genetics; D005260:Female; D012739:Gonadal Steroid Hormones / Q000009:adverse effects*; D020249:Hormone Replacement Therapy / Q000009:adverse effects*; D006801:Humans; D012307:Risk Factors; D013997:Time Factors; D014481:United States
D003278:Contraceptives, Oral, Hormonal; D012739:Gonadal Steroid Hormones